Fragility fractures and bone mineral density in HIV positive women: A case-control population-based study

Osteoporosis International

Volumn 18, Issue 10, 2007, Pages 1345-1353

  Prior, J ^a   Burdge, D ^a   Maan, E ^b   Milner, R ^b   Hankins, C ^c   Klein, M ^d   Walmsley, S ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c UNITED NATIONS   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone mineral density; Case population control; Fragility fractures; HIV positive; Premenopausal; Women

Indexed keywords

ANTIRETROVIRUS AGENT; GLUCOCORTICOID;

ADULT; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; BODY MASS; BONE DENSITY; BONE METABOLISM; CALCIUM INTAKE; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OSTEOLYSIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE DENSITY; CANADA; EPIDEMIOLOGIC METHODS; FEMALE; FRACTURES, BONE; FRACTURES, SPONTANEOUS; HIV SEROPOSITIVITY; HUMANS; OSTEOPOROSIS; PREMENOPAUSE; SOCIOECONOMIC FACTORS;

EID: 34548575884     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0428-7     Document Type: Article

References (25)

1. Thomas J, Doherty SM (2003) HIV infection-a risk factor for osteoporosis. J Acquir Immune Defic Syndr 33(3):281-291
2. Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G et al (2001) Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 15(1):137-138
3. Dolan SE, Huang JS, Killilea KM, Sullivan MP, Aliabadi N, Grinspoon S (2004) Reduced bone density in HIV-infected women. AIDS 18(3):475-483
4. Stephens EA, Das R, Madge S, Barter J, Johnson MA (1999) Symptomatic osteoporosis in two young HIV-positive African women. AIDS 13(18):2605-2606
5. McComsey GA, Huang JS, Woolley IJ, Young B, Sax PE, Gerber M et al (2004) Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management. J Int Assoc Physicians AIDS Care (Chic.Ill.) 3(3):86-91
6. Yin M, Dobkin J, Brudney K, Becker C, Zadel JL, Manandhar M et al (2005) Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos.Int published on-line March 2005
7. Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F et al (2004) Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 48(1):39-48
8. Martin K, Lawson-Ayayi S, Miremont-Salame G, Blaizeau MJ, Balestre E, Lacoste D et al (2004) Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002). HIV Med 5(6):421-426
9. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17(13):1917-1923
10. Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Prior JC et al (2000) Estimation of prevalence of low bone density in Canadian women and men using a population-specific DEXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897-904
11. Loiseau-Peres S, Delaunay C, Poupon S, Lespessailles E, Ballouche N, Arsac P et al (2002) Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine 69(5):482-485
12. O'Neil TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ et al (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Mineral Res 11:1010-1018
13. Hankins C, Lapointe N, Walmsley S (1998) Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group. CMAJ 159(11):1359-1365
14. Kreiger N, Tenenhouse A, Joseph L, Mackenzie MD, Poliquin S, Brown JP et al (1999) The Canadian Multicentre Osteoporosis Study (CaMos): Background, rationale, methods. Can J Aging 18:376-387
15. Archibald, C. HIV/AIDS EPI Updates. http://www.phac-aspc.gc.ca. 1-13-2006. Ref Type: Electronic Citation
16. Pearson D, Cawte SA, Green DJ (2002) A comparison of phantoms for cross-calibration of lumbar spine DXA. Osteoporos Int 13(12):948-954
17. Petit MA, Beck TJ, Lin HM, Bentley C, Legro RS, Lloyd T (2004) Femoral bone structural geometry adapts to mechanical loading and is influenced by sex steroids: The Penn State Young Women's Health Study. Bone 35(3):750-759
18. Luckey MM, Wallenstein S, Lapinski R, Meier DE (1996) A prospective study of bone loss in African-American and White women-a clinical research center study. J Clin Endocrinol Metab 81:2948-2956
19. Sowers M, Randolph JF, Crutchfield M, Jannausch ML, Shapiro B, Zhang B et al (1998) Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass. J Bone Min Res 13(7):1191-1202
20. Prior JC, Vigna YM, Schechter MT, Burgess AE (1990) Spinal bone loss and ovulatory disturbances. N Engl J Med 323:1221-1227
21. Sioban H, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X et al (2000) Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr 24:68-75
22. Money DM, Arikan YY, Remple V, Sherlock C, Craib K, Birch P et al (2003) Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus. Am J Obstet Gynecol 188(1):122-128
23. Clark RA, Mulligan K, Stamenovic E, Chang B, Watts H, Benson C (2001) Frequency of anovulation and early menopause among women enrolled in selected adult aids clinical trials group studies. JID 184:1325-1327
24. Swain MC, Bulbrook RD, Hayward JL (1974) Ovulatory failure in a normal population and in patients with breast cancer. J Obstet Gynaecol Br Commonw 81(8):640-643
25. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC (1994) Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med 96:521-530